IRVINE, Calif., Oct. 09, 2017 -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against TransDigm Group Incorporated (“TransDigm” or the “Company”) (NYSE:TDG). Investors who purchased or otherwise acquired TransDigm shares from May 10, 2016 through January 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm by October 10, 2017, the lead plaintiff motion deadline.
If you purchased TransDigm shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.
The Complaint alleges that during the Class Period, TransDigm made false and/or misleading statements and/or failed to disclose: that the Company’s growth and profitability were artificially inflated as a result of its illicit business practices; that TransDigm used exclusive distributors to make noncompetitive government bids seems competitive; that the Company’s subsidiaries failed to list TransDigm as a parent entity when submitting government bids; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this news was announced, shares of TransDigm dropped in value materially, which caused investors harm according to the lawsuit.
If you want to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at [email protected].
This press release may be considered Attorney Advertising in certain jurisdictions.
Contact
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
[email protected]


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 



